BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6457568)

  • 1. Topical erythromycin vs blank vehicle in a multiclinic acne study.
    Jones EL; Crumley AF
    Arch Dermatol; 1981 Sep; 117(9):551-3. PubMed ID: 6457568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a new erythromycin solution for acne vulgaris.
    Rivkin L; Rapaport M
    Cutis; 1980 May; 25(5):552-5. PubMed ID: 6445816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new salt of erythromycin (A-137 or erythromycin lauryl sulfate) in the topical treatment of acne].
    Pérez López M; Moragas Viñas JM
    Med Cutan Ibero Lat Am; 1982; 10(3):151-8. PubMed ID: 6218350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.
    Korting HC; Braun-Falco O
    Drugs Exp Clin Res; 1989; 15(9):447-51. PubMed ID: 2534292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G; Holland KT; Nenoff P
    Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical erythromycin solution in acne. Results of a multiclinic trial.
    Dobson RL; Belknap BS
    J Am Acad Dermatol; 1980 Nov; 3(5):478-82. PubMed ID: 6452463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne].
    Rozman TA; Klövekorn G; Kompa H
    Z Hautkr; 1984 Dec; 59(23):1623-34. PubMed ID: 6240840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin 2 percent gel in the treatment of acne vulgaris.
    Pochi PE; Bagatell FK; Ellis CN; Stoughton RB; Whitmore CG; Saatjian GD; Sefton J
    Cutis; 1988 Feb; 41(2):132-6. PubMed ID: 2964344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris.
    Lesher JL; Chalker DK; Smith JG; Guenther LC; Ellis CN; Voorhees JJ; Shalita AR; Klauda HC
    J Am Acad Dermatol; 1985 Mar; 12(3):526-31. PubMed ID: 3157709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris.
    Chalker DK; Shalita A; Smith JG; Swann RW
    J Am Acad Dermatol; 1983 Dec; 9(6):933-6. PubMed ID: 6227643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
    Hjorth N; Schmidt H; Thomsen K; Dela K
    Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [External erythromycin therapy of acne].
    Schmidt JB; Knobler R; Neumann R; Poitschek C
    Z Hautkr; 1983 Dec; 58(24):1754-60. PubMed ID: 6229931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical erythromycin for acne vulgaris.
    Hellgren L; Vincent J
    Dermatologica; 1980; 161(6):409-14. PubMed ID: 6452297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local treatment of acne vulgaris with erythromycin].
    Broniarczyk-Dyla G; Arkuszewska C
    Dermatol Monatsschr; 1989; 175(1):40-3. PubMed ID: 2522067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.